Published in Mol Cell Biol on June 01, 1986
Association of protein phosphatase 2A with polyoma virus medium tumor antigen. Proc Natl Acad Sci U S A (1990) 3.76
Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Implications for cellular regulation. Biochem J (1987) 2.84
Identification of binding sites on the regulatory A subunit of protein phosphatase 2A for the catalytic C subunit and for tumor antigens of simian virus 40 and polyomavirus. Mol Cell Biol (1992) 1.83
Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: abundant expression of both forms in cells. Mol Cell Biol (1997) 1.79
Cellular proteins that associate with the middle and small T antigens of polyomavirus. J Virol (1988) 1.78
Molecular cloning and sequence of cDNA encoding polyoma medium tumor antigen-associated 61-kDa protein. Proc Natl Acad Sci U S A (1989) 1.69
Medium tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with 73-kilodalton heat shock protein. J Virol (1987) 1.43
Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases. Proc Natl Acad Sci U S A (1993) 1.38
Activated Ha-ras can cooperate with defective simian virus 40 in the transformation of nonestablished rat embryo fibroblasts. J Virol (1987) 1.36
Interactions between polyomavirus medium T antigen and three cellular proteins of 88, 61, and 37 kilodaltons. J Virol (1987) 1.36
Constant expression and activity of protein phosphatase 2A in synchronized cells. Mol Cell Biol (1991) 1.23
Homologous cellular proteins associated with simian virus 40 small T antigen and polyomavirus medium T antigen. J Virol (1988) 1.21
Novel monoclonal antibodies that differentiate between the binding of pp60c-src or protein phosphatase 2A by polyomavirus middle T antigen. J Virol (1993) 1.12
Characterization of the interaction of polyomavirus middle T antigen with type 2A protein phosphatase. J Virol (1992) 1.11
Natural biology of polyomavirus middle T antigen. Microbiol Mol Biol Rev (2001) 1.02
Protein phosphatases and DNA tumor viruses: transformation through the back door? Cell Regul (1991) 1.00
The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature (1984) 28.58
Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature (1984) 25.71
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry (1978) 22.56
Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci U S A (1980) 22.30
Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses. J Virol (1983) 7.22
Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature (1983) 7.20
Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature (1985) 7.10
Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus. Cell (1980) 6.76
A one-step purification of membrane proteins using a high efficiency immunomatrix. J Biol Chem (1982) 6.70
Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein. Nature (1981) 6.70
Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation. EMBO J (1985) 5.14
Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation. Cell (1984) 5.05
The roles of individual polyoma virus early proteins in oncogenic transformation. Nature (1982) 4.57
Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro. J Biol Chem (1984) 4.20
Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol. Proc Natl Acad Sci U S A (1984) 3.84
The complex of polyoma virus middle-T antigen and pp60c-src. EMBO J (1984) 3.57
Complexes of polyoma virus medium T antigen and cellular proteins. Proc Natl Acad Sci U S A (1985) 3.42
Receptors and phosphoinositide-generated second messengers. Annu Rev Biochem (1985) 3.08
Tumor antigens induced by nontransforming mutants of polyoma virus. Cell (1978) 2.92
New classes of viable deletion mutants in the early region of polyoma virus. J Virol (1979) 2.75
Transforming protein of avian sarcoma virus UR2 is associated with phosphatidylinositol kinase activity: possible role in tumorigenesis. Proc Natl Acad Sci U S A (1984) 2.23
Thin-layer chromatography of the phosphoinositides. J Lipid Res (1968) 2.16
Antibodies specific for the polyoma virus middle-size tumor antigen. Proc Natl Acad Sci U S A (1981) 2.02
Identification of DNA sequence changes leading to loss of transforming ability in polyoma virus. J Biol Chem (1980) 1.89
Inositol 1,4,5-trisphosphate induces calcium release from sarcoplasmic reticulum of skeletal muscle. Nature (1985) 1.78
Purification of polyoma virus medium-size tumor antigen by immunoaffinity chromatography. Proc Natl Acad Sci U S A (1982) 1.74
Middle tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with pp60c-src. J Virol (1985) 1.71
DNA sequences of polyoma virus early deletion mutants. J Virol (1981) 1.51
Phosphatidylinositol kinase activity in virus-transformed and nontransformed cells. Mol Cell Biol (1985) 1.11
Evidence from two transformed cell lines that the phosphorylations of peptide tyrosine and phosphatidylinositol are catalyzed by different proteins. Proc Natl Acad Sci U S A (1985) 0.97
Head and neck cancer. N Engl J Med (2001) 7.32
Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res (1996) 4.89
Antibodies specific for the carboxy- and amino-terminal regions of simian virus 40 large tumor antigen. Proc Natl Acad Sci U S A (1980) 4.04
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet (1995) 3.76
Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol Rev (1993) 3.62
Complexes of polyoma virus medium T antigen and cellular proteins. Proc Natl Acad Sci U S A (1985) 3.42
Nucleotide sequence of the envelope gene of Friend murine leukemia virus. J Virol (1983) 3.41
Sequencing of the 16S-23S spacer in a ribosomal RNA operon of Zea mays chloroplast DNA reveals two split tRNA genes. Cell (1981) 3.40
Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation (1992) 3.27
The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol (1992) 3.19
Simian virus 40 large T antigen is phosphorylated at multiple sites clustered in two separate regions. J Virol (1982) 3.18
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res (1996) 3.18
Amino acid sequence homology between polyoma and SV40 tumour antigens deduced from nucleotide sequences. Nature (1978) 3.11
Molecular analysis of the envelope gene and long terminal repeat of Friend mink cell focus-inducing virus: implications for the functions of these sequences. J Virol (1984) 3.09
Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med (1996) 2.95
Initiation of DNA-dependent RNA synthesis and the effect of heparin on RNA polymerase. Eur J Biochem (1967) 2.87
Control of protein phosphatase 2A by simian virus 40 small-t antigen. Mol Cell Biol (1991) 2.80
Monoclonal antibodies specific for the carboxy terminus of simian virus 40 large T antigen. J Virol (1984) 2.41
ALK+ lymphoma: clinico-pathological findings and outcome. Blood (1999) 2.38
Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res (2001) 2.18
Immunofluorescent localization of the transforming protein of Rous sarcoma virus with antibodies against a synthetic src peptide. Proc Natl Acad Sci U S A (1982) 2.18
Influence of salts on RNA synthesis by DNA-dependent RNA-polymerase from Escherichia coli. Eur J Biochem (1967) 2.06
Structural repertoire of the human VH segments. J Mol Biol (1992) 2.06
The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res (1993) 2.05
A multicenter study of treatment of primary CNS lymphoma. Neurology (2002) 2.04
Antibodies specific for the polyoma virus middle-size tumor antigen. Proc Natl Acad Sci U S A (1981) 2.02
Psychotropic drugs and preschoolers. Med J Aust (2000) 2.02
A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library. Nucleic Acids Res (1998) 2.01
Protein synthesis in Simian virus 40-infected monkey cells. Proc Natl Acad Sci U S A (1972) 2.01
DNA-binding activity of simian virus 40 large T antigen correlates with a distinct phosphorylation state. J Virol (1984) 2.01
Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen. Mol Cell Biol (1991) 1.99
Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation (1998) 1.95
Evidence for simian virus 40 (SV40) coding of SV40 T-antigen and the SV40-specific proteins in HeLa cells infected with nondefective adenovirus type 2-SV40 hybrid viruses. J Virol (1977) 1.94
Experience, knowledge and attitudes of mental health staff regarding patients' problematic drug and alcohol use. Aust N Z J Psychiatry (1999) 1.94
On the nature of crossreactions observed with antibodies directed to defined epitopes. Proc Natl Acad Sci U S A (1982) 1.89
Identification of binding sites on the regulatory A subunit of protein phosphatase 2A for the catalytic C subunit and for tumor antigens of simian virus 40 and polyomavirus. Mol Cell Biol (1992) 1.83
A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. Nat Genet (1994) 1.81
The polypeptides of adenovirus. IV. Detection of early and late virus-induced polypeptides and their distribution in subcellular fractions. Virology (1974) 1.80
Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res (1996) 1.80
Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: abundant expression of both forms in cells. Mol Cell Biol (1997) 1.79
Purification of polyoma virus medium-size tumor antigen by immunoaffinity chromatography. Proc Natl Acad Sci U S A (1982) 1.74
Intermolecular disulfide bonds: an important structural feature of the polyoma virus capsid. Cold Spring Harb Symp Quant Biol (1975) 1.72
Antiserum specific for the carboxy terminus of the transforming protein of Rous sarcoma virus. J Virol (1982) 1.68
Donor-acceptor interaction and the peculiar structures of dications. J Am Chem Soc (1986) 1.67
STP position paper: best practice guideline for the routine pathology evaluation of the immune system. Toxicol Pathol (2005) 1.67
Clinical practice recommendations for depression. Acta Psychiatr Scand Suppl (2009) 1.65
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. Am J Pathol (1998) 1.64
Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin. AIDS (2001) 1.64
Protein microarrays for gene expression and antibody screening. Anal Biochem (1999) 1.64
Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study. J Natl Cancer Inst (2001) 1.63
Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang (1998) 1.62
Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas. Blood (1994) 1.58
Modified DNA-dependent RNA polymerase from E. coli infected with bacteriophage T4. Biochem Biophys Res Commun (1968) 1.57
Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene. Oncogene (2001) 1.56
Removal of serine phosphates from simian virus 40 large T antigen increases its ability to stimulate DNA replication in vitro but has no effect on ATPase and DNA binding. J Virol (1987) 1.56
PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement. J Am Coll Cardiol (2000) 1.56
Molecular model of the A subunit of protein phosphatase 2A: interaction with other subunits and tumor antigens. J Virol (1994) 1.56
The xanthogranulomatous process. Xanthogranulomatous inflammation. Pathol Res Pract (1988) 1.55
A liver storage test for the assessment of vitamin A. Biochem J (1944) 1.55
Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases. Gut (1987) 1.54
Simian virus 40-specific proteins in HeLa cells infected with nondefective adenovirus 2-simian virus 40 hybrid viruses. J Virol (1975) 1.54
From Karrawingi the emu to Care factor zero. Mental health issues in contemporary Australian adolescent literature. Med J Aust (2001) 1.53
Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy. J Thromb Haemost (2010) 1.52
Discordant HHV8 detection in a young HIV-negative patient with Kaposi's sarcoma and sarcoidosis. Clin Infect Dis (2001) 1.52
Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology (2011) 1.50
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Simian virus to (SV40) tumor-specific proteins in nucleus and plasma membrane of HeLa cells infected by adenovirus 2-SV40 hybrid virus Ad2+ND2. Proc Natl Acad Sci U S A (1976) 1.49
Allelotype of head and neck squamous cell carcinoma. Cancer Res (1994) 1.47
Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. Am J Pathol (1999) 1.47
Analysis of human herpesvirus type 8 infection in AIDS-related and AIDS-unrelated primary central nervous system lymphoma. J Infect Dis (1997) 1.47
A human cDNA library for high-throughput protein expression screening. Genomics (2000) 1.46
Metastasizing dermal squamomelanocytic tumour: more evidences. J Eur Acad Dermatol Venereol (2011) 1.46
The Opitz syndrome gene product, MID1, associates with microtubules. Proc Natl Acad Sci U S A (1999) 1.44
Medium tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with 73-kilodalton heat shock protein. J Virol (1987) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
P27 and P53 gene polymorphisms and restenosis following coronary implantation of drug-eluting stents. Cardiology (2008) 1.42
B-cell control region at the 5' end of a major histocompatibility complex class II gene: sequences and factors. Mol Cell Biol (1988) 1.41
Perioperative effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg (1997) 1.41
Occupation and soft-tissue sarcoma in northeastern Italy. Cancer Causes Control (1992) 1.41
Production and use of antibodies against synthetic peptides. J Immunol Methods (1986) 1.41
Way out of tune: lessons from Shine and its exposé. Aust N Z J Psychiatry (2000) 1.41
[Isolated myocardial noncompaction in childhood-case report and review of the literature]. Z Kardiol (2003) 1.40
In vitro phosphorylation of SV40 large T antigen. Virology (1988) 1.40
Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res (1994) 1.40
G protein beta3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placement. Atherosclerosis (2000) 1.39
Nerve reconstruction with glycerol-preserved allogenic grafts in the rat. Microsurgery (1993) 1.39
Prolonged seizures in the young. J ECT (1998) 1.39
Expression of natural killer antigens in a subset of 'non-T, non-B lymphoma/leukaemia with histiocytic features'. Br J Haematol (1990) 1.39
Epidemic Kaposi's sarcoma in Italy, a country with intravenous drug abusers as the major group at risk for AIDS: report of 60 cases. AIDS (1989) 1.38
Patient, client, consumer? Aust N Z J Psychiatry (1999) 1.38
Phosphorylation of SV40 large T antigen. Cold Spring Harb Symp Quant Biol (1980) 1.36
Interactions between polyomavirus medium T antigen and three cellular proteins of 88, 61, and 37 kilodaltons. J Virol (1987) 1.36
Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev (2008) 1.36
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood (1999) 1.35
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost (2006) 1.30